The clinical mass spectrometry market is estimated to be valued at US$ 6.37 Bn in 2023 and is expected to exhibit a CAGR of 6.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Clinical mass spectrometry is a technique employed for analyzing small molecules and biomolecules like proteins, peptides, glycans. It finds wide applications in proteomics, ... Read more
